Omega-3 Fatty Acids May Improve Cancer Treatment
28 Jul 2015 --- Adding omega-3 fatty acids to anti-tumor medications may improve treatment response and quality of life for cancer patients according to a new study by researchers at the University Hospitals of Leicester in the United Kingdom.
Patients were given 1,000 mg of gemcitabine weekly followed by up to 100 g of omega-3 rich lipid emulsion for three weeks followed by a rest week. This was continued for up to six cycles, progression, unacceptable toxicity, patient request, or death.
The study found evidence of activity in response and disease stabilization rates, reduction in liver metastasis volume, and improved quality of life scores in this group of patients.
While this is the first study to use omega-3 fatty acids with a chemotherapy agent in a cancer setting, the researchers believe the results are encouraging enough to warrant further investigation in a randomized phase III trial.
Upcoming webinars
Advancing HMO science with integrity: A look inside Novonesis' labs
Novonesis
Probiotic Innovation in Menopause: Expert Perspectives and Clinical Evidence
AB-BIOTICS Kaneka Probiotics
Upliving with Postbiotics: Discover the power of LAC-Living+ in Mood
Morinaga Milk Industry Co., Ltd.
